Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

59.57 +0.90 (+1.53%)
Streaming Delayed Price Updated: 12:45 PM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
41 42 Next >
7 Analysts Have This to Say About CVS Health
Via Benzinga
Buffett, Dalio, Einhorn, Ackman: The Masters Of Wall Street Shuffle Their Stock Decks In Q3
Recent 13F filings unveil the latest investment moves by top hedge funds, revealing shifts in their portfolios and strategic bets in various sectors. 
Via Benzinga
Ray Dalio's Bridgewater Bets Big On Retail With Stakes In Coca-Cola, Costco, And Walmart Among Top Holdings
Ray Dalio's Bridgewater's latest 13F report for Q3 2020 shows 40.63% of his portfolio invested in consumer stocks (discretionary & staples). 
Via Benzinga
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Price Over Earnings Overview: CVS Health
Via Benzinga
What 7 Analyst Ratings Have To Say About CVS Health
Via Benzinga
3 value stocks you shouldn't let go of this quarter
The market has created the perfect opportunity for you to have your cake and eat it too. These three value stocks will likely be portfolio residents soon 
Via MarketBeat
Topics Bankruptcy
Exposures Financial Legal
2 Dividend Stocks Near Their 52-Week Lows to Buy and Hold Forever
These longtime healthcare leaders have faced -- and overcome -- plenty of obstacles before. 
Via The Motley Fool
Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action
Amazon.Com, Inc. (NASDAQ: AMZN) has received a  
Via Benzinga
Exposures Product Safety
Top 3 Telehealth Stocks to Invest in for a Future of Virtual Care
Telehealth stocks fell out of favor after COVID-19, but their potential remains intact. Here are the companies you should be following. 
Via InvestorPlace
Exposures COVID-19
High-yield, low-beta value plays for buy-and-hold investors
High-yield stocks that trade at a value and come with a lower-than-average beta can help mitigate portfolio volatility and boost returns over time. 
Via MarketBeat
Topics Economy
Exposures Economy
Why CVS Health Stock Dropped Today
The pharmacy chain modestly lowered its full-year outlook despite strong third-quarter results. 
Via The Motley Fool
CVS Health Unusual Options Activity For October 31
Via Benzinga
3 Excellent Dividend Growth Stocks That Show No Signs of Slowing Down
These companies are committed to raising their dividend year after year for the foreseeable future. 
Via The Motley Fool
3 healthy dividend stocks for buy and hold investors
Blue chip healthcare stocks like health insurers are supported by secular tailwinds and pay reliable dividends with an outlook for health growth 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
More Than $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed slightly higher on Monday, there were a few notable insider trades. 
Via Benzinga
Don’t Get Stuck with These 3 Declining Stocks
It's time to sell these three declining stocks which have disappointed investors all year with their plummeting share values. 
Via InvestorPlace
Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest
In a recent surge of labor unrest, pharmacy employees from CVS Health Corporation (NYSE: CVS) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA) raised their voices by calling out sick or walking out... 
Via Benzinga
Earnings Preview: CVS Health
Via Benzinga
Help Grow Your Retirement Savings by Investing in These 3 Safe Stocks for the Long Haul
These are stocks you can comfortably hold in your portfolio for decades. 
Via The Motley Fool
Topics Retirement
Exposures Pension
CVS Health Is Down 27% This Year. Is the Stock a Buy on the Dip?
At recent prices, the healthcare giant offers a 3.5% dividend yield. 
Via The Motley Fool
Wait for the New CEO to Get His Feet Wet Before You Trust Too Much in Walgreens' Guidance
Walgreens just hired a new CEO, which means any guidance that exists today has minimal value for investors. 
Via The Motley Fool
3 Beaten-Down, High-Yield Dividend Stocks That Wall Street Predicts Could Soar More Than 25% Over the Next 12 Months
Analysts view these dividend stocks as great rebound candidates. 
Via The Motley Fool
CVS Health (CVS) Q3 2023 Earnings Call Transcript
CVS earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
CVS Health's Health Services And Pharmacy Benefit Management Business Show Strength In Q3, But Lowers Annual GAAP EPS Outlook
CVS Health Corp's (NYSE: CVS) Q3 sales increased 10.6% Y/Y to $89.76 billion, beating the consen 
Via Benzinga
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News'
U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision
The CNN Money Fear and Greed index remained in the "Fear" zone on Tuesday. U.S. stocks closed higher on Tuesday, ahead of the Federal Reserve's monetary policy decision. The central bank is widely... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Kraft Heinz, Yum China And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Strike Alert 2023: Workers at CVS, Walgreens, Rite Aid Walk Out
Workers at pharmacy companies CVS, Walgreens and RiteAid have staged a three-day strike over unsafe and poor working conditions. 
Via InvestorPlace
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
GSK (NYSE: GSK) has reportedly taken an early lead in the race for respiratory syncytial virus (RSV) vaccine dominance, surpassing Pfizer Inc (NYSE: PFE), which previously dominated the COVID-19... 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
41 42 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.